行情

ICLR

ICLR

ICON公司
NASDAQ

实时行情|Nasdaq Last Sale

129.79
-2.41
-1.82%
盘后: 129.79 0 0.00% 16:00 04/02 EDT
开盘
132.63
昨收
132.20
最高
133.37
最低
128.79
成交量
51.30万
成交额
--
52周最高
178.99
52周最低
104.28
市值
69.60亿
市盈率(TTM)
18.85
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ICLR价格均价为171.71,最高价位193.00,最低价为131.00。

EPS

ICLR 新闻

更多
  • 6 Health Care Companies Boosting Book Value
  • GuruFocus.com · 8小时前
  • Wells Fargo Maintains Equal-Weight on Icon, Lowers Price Target to $140
  • Benzinga · 3天前
  • Hedge Funds Were Selling ICON Public Limited Company (ICLR) Before The Coronavirus
  • Insider Monkey · 03/23 13:56
  • 6 Guru Stocks Expected to Boost Earnings
  • GuruFocus.com · 03/19 22:36

所属板块

生物技术和医学研究
+3.32%
制药与医学研究
+2.80%

热门股票

代码
价格
涨跌幅

ICLR 简况

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
展开

微牛提供ICON PLC(NASDAQ-ICLR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ICLR股票新闻,以帮助您做出投资决策。